Table 3.
Characteristic | HPV-seropositive (N = 804 women typesb) | ||
---|---|---|---|
| |||
aORc | (95% CI) | p-value | |
Time-fixed variables from enrollment survey | |||
| |||
Body Mass Index (kg/m2)d | |||
17 – 25 | 1.0 | -- | -- |
25 – 29.9 | 1.5 | (0.6, 3.7) | 0.35 |
30 – 51 | 2.7 | (0.99, 7.1) | 0.05 |
Lifetime number of sex partnerse | |||
0 – 4 | 1.0 | -- | -- |
5 – 11 | 3.3 | (0.9, 11.3) | 0.06 |
12+ | 1.3 | (0.3, 5.0) | 0.72 |
Incident type-specific high-risk HPV detection was defined as the first DNA-positive sample for a HPV type not detected at enrollment; samples after each type-specific first positive detection were considered censored.
246 women contributed 804 women-types to the seropositive analysis.
Adjusted odds ratio adjusted for all other variables in the table
There was a borderline statistically significant linear categorical dose-response relationship between increasing BMI categories and likelihood of hrHPV detection (p=0.06 by trend test).
Lifetime number of sex partners categorized based on approximate tertiles